Skip to main content
ACoP 2024 Main banner
Final Program


Conference Program
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back

Oleg Demin Jr (he/him/his)

Scientific Director, Oncology & Immuno-Oncology Quantitative Systems Pharmacology
InSysBio CY, Cyprus

Oleg Demin Jr is the Scientific Director of QSP Modeling in Oncology & Immuno-Oncology at InSysBio CY. He has over 10 years of experience in the application of mechanistic and quantitative systems pharmacology modeling to support drug R&D in various diseases and therapeutic areas, including oncology, immuno-oncology, immunology, type 2 diabetes, HCV, Alzheimer's disease, gout, celiac disease, and others. Since 2015, he has focused exclusively on oncology and immuno-oncology, including both solid tumors (melanoma, NSCLC) and hematological malignancies (AML, ALL, NHL). His current research interests include engineered cell therapies (CAR-T, TCR-T, CAR-NK, etc.), T-cell and NK-cell engagers, ADC, checkpoint inhibitors, and multispecific therapeutic antibodies.

Disclosure(s): No financial relationships to disclose

Presentation(s):